1. Search Result
Search Result
Results for "

KLF4

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Screening Libraries

1

Peptides

8

Antibodies

4

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-16291
    APTO-253
    Maximum Cited Publications
    21 Publications Verification

    LOR-253; LT-253

    c-Myc KLF Apoptosis Inflammation/Immunology Cancer
    APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through induction of the Krüppel-like factor 4 (KLF4) tumor suppressor . APTO-253 has antiarthritic activity .
    APTO-253
  • HY-12302
    Kenpaullone
    10+ Cited Publications

    9-Bromopaullone; NSC-664704

    CDK GSK-3 Cancer
    Kenpaullone is a potent inhibitor of CDK1/cyclin B and GSK-3β, with IC50s of 0.4 μM and 23 nM, and also inhibits CDK2/cyclin A, CDK2/cyclin E, and CDK5/p25 with IC50s of 0.68 μM, 7.5 μM, 0.85 μM, respectively. Kenpaullone, a small molecule inhibitor of KLF4, reduces self-renewal of breast cancer stem cells and cell motility in vitro.
    Kenpaullone
  • HY-RS16607

    Small Interfering RNA (siRNA) Others

    Klf4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Klf4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Klf4 Mouse Pre-designed siRNA Set A
    Klf4 Mouse Pre-designed siRNA Set A
  • HY-RS07341

    Small Interfering RNA (siRNA) Others

    KLF4 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    KLF4 Human Pre-designed siRNA Set A
    KLF4 Human Pre-designed siRNA Set A
  • HY-RS23041

    Small Interfering RNA (siRNA) Others

    Klf4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Klf4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Klf4 Rat Pre-designed siRNA Set A
    Klf4 Rat Pre-designed siRNA Set A
  • HY-174592

    mRNA Cancer
    Human kruppel like factor 4 (KLF4) mRNA encodes a protein that belongs to the Kruppel family of transcription factors. KLF4 protein is thought to regulate the expression of key transcription factors during embryonic development and play an important role in maintaining embryonic stem cells, and in preventing their differentiation. In addition it is also required for establishing the barrier function of the skin and for postnatal maturation and maintenance of the ocular surface.
    Human KLF4 mRNA
  • HY-131923

    Notch Cancer
    DAPM is a Notch pathway inhibitor with anticancer activity and antiproliferative effects. DAPM effectively inhibits tubular adenoma development by inhibiting cell proliferation and inducing the expression of Krüppel-like factor 4 (KLF4) and p21 in human colon cancer cells .
    DAPM
  • HY-16291A

    LOR-253 hydrochloride; LT-253 hydrochloride

    c-Myc Inflammation/Immunology
    APTO-253?(LOR-253) hydrochloride is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253?hydrochloride mediates anticancer activity via induction of Kruppel-like factor 4?(KLF4)?tumor suppressor. APTO-253?hydrochloride exhibits antiarthritic activity .
    APTO-253 hydrochloride
  • HY-121917

    c-Myc Apoptosis Inflammation/Immunology
    APTO-253 (LOR-253) hydrochloride is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 hydrochloride mediates anticancer activity via induction of Kruppel-like factor 4 (KLF4) tumor suppressor. APTO-253 hydrochloride exhibits antiarthritic activity.
    Ro 31-7837
  • HY-W072962

    Histone Methyltransferase PAK Bcl-2 Family KLF Cancer
    WX2-43 is a PRMT5-KLF4 inhibitor (Kd of 11.0 nM). WX2-43 binds to the region between amino acids L400-M500 on PRMT5. WX2-43 efficiently intercepts the interaction between KLF4 and PRMT5, and blocks KLF4 methylation. WX2-43 decreases p21 levels and increases Bax levels. WX2-43 suppresses triple negative breast tumor progression. WX2-43 can be used in the research of triple-negative breast cancer and colorectal cancer .
    WX2-43

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: